Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead
Biogen Korea has appointed Kim Chul-woong as its new general manager, tapping an executive with extensive expertise in rare and intractable diseases...
Search results for "global"
Hearing Aids Over Supplements: WHO Updates Dementia Prevention Guidance for First Time in Seven Years
More than 57 million people worldwide currently live with dementia, with approximately 10 million new cases diagnosed each year.
Heavy Coffee Consumption Can Drive Dehydration and Spike 'Bad' Cholesterol, Experts Warn
As summer heat lingers, many people reach for an iced Americano or stick strictly to hot coffee.
6 in 10 Korean Office Workers Willing to Pay for Health Management, Study Finds
A growing number of office workers in South Korea view personal health not merely as the absence of illness, but as a...
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal
Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes...
Deceptive Symptoms in Diagnostic Gaps: 88% of Pediatric Pneumonia Cases Coincide with Viruses
Diagnosing respiratory infections in infants and toddlers using virus-only testing can leave dangerous diagnostic gaps,...
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production
GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
TAVI speeds recovery without opening the chest — but age brings more to weigh
For patients diagnosed with severe aortic stenosis and their families, one question often comes first: “Can it be...
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68
Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an...
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines
South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...